title: [Demands and expectations for drug companies].
abstract: We need the surroundings in which we can conduct sciences-based safety measurements and continue to do scientific approach in order to ensure the safety of drugs and put patients and the nation at ease. It is important that we actively conduct clinical trials to evaluate the efficacy and safety of drugs, and supply the results to medical scene quickly. Japanese government draws up some plans to activate clinical trials, and intends to improve national health and promote ability of research and development of drugs. Since activation of clinical trials is important for progression of medicine too, drug companies are also expected to take part in it positively.
authors.affiliation: Ministry of Health, Labour and Welfare, Tokyo, Japan. hirayama-yoshinobu@mhlw.go.jp
authors.forename: Yoshinobu
authors.initials: Y
authors.lastname: Hirayama
mesh_terms: D002986:Clinical Trials as Topic; D055808:Drug Discovery; D004345:Drug Industry / Q000191:economics; D064420:Drug-Related Side Effects and Adverse Reactions; D019317:Evidence-Based Medicine; D005378:Financial Support; D006801:Humans; D007564:Japan; D017751:Safety Management